NOTV vs. LUNA, PMVP, PGEN, PIRS, OCGN, IGMS, OABI, PRAX, ABSI, and INMB
Should you be buying Inotiv stock or one of its competitors? The main competitors of Inotiv include Luna Innovations (LUNA), PMV Pharmaceuticals (PMVP), Precigen (PGEN), Pieris Pharmaceuticals (PIRS), Ocugen (OCGN), IGM Biosciences (IGMS), OmniAb (OABI), Praxis Precision Medicines (PRAX), Absci (ABSI), and INmune Bio (INMB).
Inotiv (NASDAQ:NOTV) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.
Luna Innovations received 181 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 61.11% of users gave Luna Innovations an outperform vote while only 48.57% of users gave Inotiv an outperform vote.
Luna Innovations has lower revenue, but higher earnings than Inotiv. Luna Innovations is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks.
Luna Innovations has a net margin of -1.82% compared to Inotiv's net margin of -5.67%. Luna Innovations' return on equity of 3.61% beat Inotiv's return on equity.
18.2% of Inotiv shares are owned by institutional investors. Comparatively, 87.5% of Luna Innovations shares are owned by institutional investors. 5.8% of Inotiv shares are owned by company insiders. Comparatively, 7.6% of Luna Innovations shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Inotiv has a beta of 3.16, indicating that its stock price is 216% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
In the previous week, Luna Innovations had 24 more articles in the media than Inotiv. MarketBeat recorded 25 mentions for Luna Innovations and 1 mentions for Inotiv. Luna Innovations' average media sentiment score of 0.05 beat Inotiv's score of 0.00 indicating that Luna Innovations is being referred to more favorably in the news media.
Inotiv currently has a consensus price target of $15.17, indicating a potential upside of 222.70%. Luna Innovations has a consensus price target of $10.00, indicating a potential upside of 257.14%. Given Luna Innovations' higher probable upside, analysts clearly believe Luna Innovations is more favorable than Inotiv.
Summary
Luna Innovations beats Inotiv on 13 of the 17 factors compared between the two stocks.
Get Inotiv News Delivered to You Automatically
Sign up to receive the latest news and ratings for NOTV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NOTV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools